NCT06232109View on ClinicalTrials.gov

Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 22, 2024

Primary Completion Date

July 3, 2024

Study Completion Date

July 3, 2024

Conditions
Drug Drug Interaction
Interventions
DRUG

Fluvoxamine

Oral

DRUG

Itraconazole

Oral

DRUG

Paroxetine

Oral

DRUG

ASN51

Oral

Trial Locations (1)

9728 NZ

ICON Groningen Van Swietenlaan 6, Groningen

Sponsors

Lead Sponsor

Asceneuron S.A.
All Listed Sponsors
lead

Asceneuron S.A.

INDUSTRY

NCT06232109 - Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects | Biotech Hunter | Biotech Hunter